HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brigitte M Pützer Selected Research

MicroRNAs (MicroRNA)

4/2020MiRNAs Targeting Double Strand DNA Repair Pathways Lurk in Genomically Unstable Rare Fragile Sites and Determine Cancer Outcomes.
1/2019p73-Governed miRNA Networks: Translating Bioinformatics Approaches to Therapeutic Solutions for Cancer Metastasis.
8/2016Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient Outcome.
9/2014Emerging from the shade of p53 mutants: N-terminally truncated variants of the p53 family in EMT signaling and cancer progression.
6/2013Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
7/2010Checks and balances: E2F-microRNA crosstalk in cancer control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brigitte M Pützer Research Topics

Disease

45Neoplasms (Cancer)
01/2022 - 04/2002
12Neoplasm Metastasis (Metastasis)
01/2019 - 01/2004
11Melanoma (Melanoma, Malignant)
12/2020 - 01/2004
8Carcinogenesis
04/2020 - 04/2002
5Thyroid Neoplasms (Thyroid Cancer)
01/2017 - 08/2004
3Disease Progression
12/2020 - 08/2016
3Infections
08/2010 - 02/2005
2Genomic Instability
04/2020 - 07/2019
2Lymphatic Metastasis
01/2018 - 08/2016
2Carcinoma (Carcinomatosis)
08/2016 - 09/2014
2Hepatocellular Carcinoma (Hepatoma)
10/2011 - 01/2004
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2003 - 04/2002
1Fragile X Syndrome (Martin Bell Syndrome)
04/2020
1Pre-Eclampsia (Preeclampsia)
01/2020
1Skin Neoplasms (Skin Cancer)
09/2019
1Autoimmune Diseases (Autoimmune Disease)
09/2019
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2019
1Sepsis (Septicemia)
01/2019
1Penile Neoplasms (Penile Cancer)
01/2018
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
01/2017
1Breast Neoplasms (Breast Cancer)
01/2017
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2016
1Edema (Dropsy)
02/2016
1Necrosis
02/2016
1Central Nervous System Diseases (CNS Diseases)
01/2016
1Liver Diseases (Liver Disease)
01/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2016
1Fibrosis (Cirrhosis)
11/2012
1Osteosarcoma (Osteogenic Sarcoma)
11/2006
1Persistent Infection
09/2004
1Papillary Thyroid Cancer
07/2004
1Cysts
02/2004
1Nevus (Nevi)
01/2004
1Pigmented Nevus (Melanocytic Nevus)
01/2004
1Retinoblastoma (Glioblastoma, Retinal)
04/2003
1medullary Thyroid cancer
12/2002

Drug/Important Bio-Agent (IBA)

12Protein Isoforms (Isoforms)IBA
01/2021 - 04/2002
10Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2002
9Transcription Factors (Transcription Factor)IBA
12/2020 - 02/2013
8E2F1 Transcription FactorIBA
07/2019 - 04/2006
7Pharmaceutical PreparationsIBA
09/2019 - 06/2003
6MicroRNAs (MicroRNA)IBA
04/2020 - 07/2010
5Peptides (Polypeptides)IBA
01/2016 - 02/2005
3Biological ProductsIBA
08/2009 - 01/2008
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
04/2020 - 07/2019
2E2F Transcription FactorsIBA
12/2018 - 07/2010
2Insulin-Like PeptidesIBA
12/2018 - 09/2014
2Biomarkers (Surrogate Marker)IBA
01/2018 - 08/2016
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017 - 08/2004
2LigandsIBA
12/2013 - 02/2005
2hepatitis B virus X proteinIBA
10/2011 - 02/2004
2Antineoplastic Agents (Antineoplastics)IBA
08/2010 - 07/2003
2Oncogene Proteins (Oncogene Protein)IBA
08/2009 - 04/2003
2Tumor Protein p73IBA
12/2005 - 01/2004
2Peptide LibraryIBA
11/2005 - 02/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2020
1ProgranulinsIBA
01/2020
1Melanins (Melanin)IBA
01/2019
1Hyaluronic Acid (Hyaluronan)IBA
01/2019
1argatroban (MPQA)FDA Link
01/2019
1EnzymesIBA
01/2019
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2019
1CyclinsIBA
01/2018
1Aquaporins (Water Channels)IBA
02/2016
1InterleukinsIBA
02/2016
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
01/2016
1Fibronectins (Fibronectin)IBA
11/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2014
1RNA (Ribonucleic Acid)IBA
08/2014
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2013
1Complement System Proteins (Complement)IBA
12/2013
1Vascular Endothelial Growth Factor CIBA
12/2013
1Cytostatic AgentsIBA
06/2013
1dibutyldichlorotinIBA
11/2012
1NestinIBA
08/2010
1Drug CombinationsIBA
08/2010
1Small Interfering RNA (siRNA)IBA
01/2010
1Cadherins (E-Cadherin)IBA
01/2010
1Growth Factor ReceptorsIBA
01/2010
1ErbB Receptors (EGF Receptor)IBA
01/2010
1PolyethyleneimineIBA
08/2009
1Antisense OligonucleotidesIBA
08/2009
1Endoplasmic Reticulum Chaperone BiPIBA
12/2008
1Green Fluorescent ProteinsIBA
11/2007
1ProteomeIBA
11/2006
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2005
1AcidsIBA
11/2005
1Integrin alphaVIBA
02/2005
1Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA
02/2005
1Interferon-alpha (Interferon Alfa)IBA
09/2004
1Phosphotransferases (Kinase)IBA
07/2004
1tyrosine receptor (receptor, tyrosine)IBA
07/2004
1Retinoblastoma ProteinIBA
04/2003
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2002

Therapy/Procedure

23Therapeutics
01/2022 - 04/2002
4Drug Therapy (Chemotherapy)
12/2018 - 04/2008
3Immunotherapy
09/2019 - 04/2002
1Ligation
01/2019
1Punctures
01/2019
1Intravenous Injections
11/2005